OverviewChartNewsTraderScreen

BNP Paribas Discount Zert BNTX 29.../  DE000PC1TF91  /

Frankfurt Zert./BNP
5/17/2024  10:20:12 AM Chg.+0.060 Bid11:14:19 AM Ask11:14:19 AM Underlying Strike price Expiration date Option type
79.900EUR +0.08% 79.860
Bid Size: 2,600		 80.110
Ask Size: 2,600		 BioNTech SE - USD 12/29/2025 Call
GlobeNewswire 5/9 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 5/6 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 5/6 Europe mixed premarket with data on the limelight
GlobeNewswire 5/2 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 4/22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 4/10 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 4/7 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 4/4 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 3/28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/27 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
TeleTrader 3/20 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 3/20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
TeleTrader 3/20 Europe mixed premarket amid data
GlobeNewswire 3/14 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire 3/12 The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...
GlobeNewswire 3/11 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire 3/11 FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead ...
GlobeNewswire 3/11 DEADLINE ALERT for DADA, BNTX, and CMI: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 3/11 BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline ...
GlobeNewswire 3/11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 3/11 BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Sub...
Newsfile Corp 3/11 BNTX DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioNTech SE Investors to Secure Couns...
GlobeNewswire 3/9 BIONTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit H...